Allergan (AGN) Tops Q3 EPS by 30c

Allergan (NYSE: AGN) reported Q3 EPS of $3.48, $0.30 better than the analyst estimate of $3.18. Revenue for the quarter came in at $4.1 billion versus the consensus estimate of $4.03 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• SanDisk upgraded at JPMorgan after investor day; shares climb